Charged Alpha
CHARGED ALPHA · RESEARCH PACKET
Companion to the Q2 FY2026 earnings episode · published September 10, 2026

DBI: Who Keeps the Tariff Windfall?

Designer Brands Inc. · NYSE: DBI · Class A common sharesQuarter ended August 1, 2026Results September 10, 2026 (September 10 release)Footwear retail and brandsPresented by Hudson & Lana
SELLConviction 3 / 5Uncertainty: High
Fair value (base)$3.50range $1.00–$8.00
Price, Sep 10 reference$5.99-42% to base
Probability-weighted$3.65-39% expected

The business is improving; the common claim still needs a lower price. Full tariff and financing bridges, debt-like claims and potential dilution matter more than the adjusted EPS headline.

Layer 1 · fast

The 60-second read

Q2 revenue$730.63M−1.2% year over year
Retail comparable sales−2.6%Demand still soft
Full ex-refund gross margin45.14%Issuer adjusted is 47.9%
Full ex-refund EBIT$19.19MBelow prior $26.14M
H1 ordinary FCF$25.99MIncludes rounded $20.7M refund benefit
Net modeled claims$438.84MBefore division by 66M model shares

Five things to know

  1. Three gross margins matter. 50.0% reported, 47.9% issuer adjusted and 45.14% after full recovery removal.
  2. The Investor was paid. $18.3M remittance includes principal and interest; cash already reflects it.
  3. Minority earnings are not all common earnings. Adjusted net income adds back Topo attribution.
  4. Debt extends beyond headline borrowing. Finance leases add an inferred $29.46M.
  5. Price must compensate for the claims. $3.50 base value versus $5.99 reference, with high uncertainty.
Layer 1 · the call

Three scenarios, one probability-weighted number

Analyst judgments, not company guidance. Same claim bridge isolates business-value outcomes.

Common-share scenarios
BearBear: $1.00$1.00BaseBase: $3.50$3.50BullBull: $8.00$8.00WeightedWeighted: $3.65$3.65ReferenceReference: $5.99$5.99
BearBear: $1.00$1.00BaseBase: $3.50$3.50BullBull: $8.00$8.00WeightedWeighted: $3.65$3.65ReferenceReference: $5.99$5.99
Show the data
MeasureValue
Bear1.00
Base3.50
Bull8.00
Weighted3.65
Reference5.99
ScenarioProbability12-month valuevs $5.99What has to happenThe arithmetic
Bear30%$1.00−83%Retail pressure and refinancing absorb the recovery.$504.844M enterprise less $438.844M claims, divided by 66M model shares.
Base50%$3.50−42%Modest growth and controlled costs; base rounded from $3.60 route blend.$669.844M enterprise less $438.844M claims, divided by 66M model shares.
Bull20%$8.00+34%Stronger demand and brand mix produce substantially higher durable margins.$966.844M enterprise less $438.844M claims, divided by 66M model shares.
30% × $1 + 50% × $3.50 + 20% × $8 = $3.65. Conditional entry $2.45, exactly 30% below base.
Layer 1 · falsifiable

Signposts: what would change our mind

SignpostNow (Q2 FY2026)Green ifRed ifNext check
Retail comps−2.6%At least 0%Below −4%Next Q3; review Dec 15, 2026
Full ex-refund gross margin45.14%At least 45.5%Below 44%Next Q3; review Dec 15, 2026
Full ex-refund EBIT$19.187MAt least $35MBelow $20MNext Q3; review Dec 15, 2026
Liquidity and claims$51.591M cash; $455.435M debt + finance leasesCash and claims improveCash below $35M or debt claims above $475MNext Q3; review Dec 15, 2026
Potential ownership66M gross modelStable claim countAbove 69MNext Q3 filing; review Dec 15, 2026

No verified prior packet signpost scorecard claimed. Review dates are analytical deadlines, not confirmed company reporting dates.

The tape

Designer Brands has a real operating improvement, an unusually complicated tariff windfall and an expensive capital structure. Those can all be true together. Our call is SELL, conviction 3/5, high uncertainty, with $3.50 base fair value against the September 10 reference price of $5.99. The three-route valuation blends to $3.60 before rounding. The stock therefore needs a stronger durable recovery than our base case delivers; an earnings increase alone does not establish a bargain for common shareholders.

The saved quote rose 14.75% from $5.22 on September 10, with 1.62M shares traded. We have the same-day release and market record, but have not independently established the exact first public-release clock or isolated every other cause of trading. This is a same-day move, not a precise event-study claim. The provider market capitalization uses a share count that differs from the filing, and its descriptive profile still carries obsolete three-segment language. We use primary filings for the business and share analysis.

Reference price and two-year daily closes · September 2024–September 10, 2026. Valuation uses August 1 financial claims; no later cash results invented.
$0.00$2.50$5.00$7.50$10.00Base $3.50Bear $1Bull $8Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26$5.99
$0.00$2.50$5.00$7.50$10.00Base $3.50Bear $1Bull $8Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26$5.99
Show the data
DateClose
2024-09-03$6.13
2024-12-02$5.52
2025-03-06$4.10
2025-06-05$3.64
2025-09-05$4.73
2025-12-04$4.71
2026-03-09$6.02
2026-06-08$8.88
2026-09-08$5.20

A low share price is not a low enterprise valuation. At $5.99 and our deliberately gross 66M modeling denominator, common equity represents $395.34M. The modeled debt, finance leases, minority claim and cash reserve, net of recorded cash, add another $438.844M. The resulting $834.184M business-value hurdle is materially larger than the quoted equity headline. Changing the potential share count changes that hurdle, which is why the packet shows both reported and modeled ownership rather than substituting one for the other.

Decision measureValue
Rating / conviction / uncertaintySELL / 3 of 5 / High
Base / scenario-weighted value$3.50 / $3.65
Route blend before rounding$3.59996
Reference price / downside to base$5.99 / 41.6%
Conditional entry$2.45; business conditions must hold
Current release; saved FMP quote and analyst valuation.

The print

The issuer calls this Q2 FY2026: thirteen weeks ended August 1, 2026, with the release dated September 10. Fiscal labels matter: FY2025 ended January 31, 2026. Revenue fell 1.2% to $730.631M even as reported operating profit more than doubled. GAAP diluted EPS rose to $0.31 from the restated $0.21. The issuer’s adjusted EPS was $0.34 versus $0.33, but that adjustment does not remove all tariff benefits and adds back income attributed to the redeemable minority interest. Neither the growth headline nor the adjusted label is sufficient by itself.

Q2 result, $M except EPSFY2026FY2025 restated
Sales730.631739.762
Gross profit365.355322.493
Operating expenses313.412297.462
Operating equity income2.782.578
Operating profit54.72326.143
Consolidated net income20.41710.874
Income attributed to Topo minority2.860.339
Income attributable to DBI17.55710.535
Diluted EPS / issuer adjusted EPS$0.31 / $0.34$0.21 / $0.33
Current 10-Q; non-GAAP tables.

The full first half is less dependent on the latest quarter than the headline suggests. Revenue was essentially flat at $1,426.981M. Operating profit excluding the entire tariff-cost recovery was $38.057M, compared with $18.236M reported in the restated prior half. Q1 supplied a substantial improvement. Q2 alone, however, produced $19.187M operating profit after the same complete refund removal, below $26.143M a year earlier. This combination argues for a recovery that needs confirmation, not for either dismissing the improvement or projecting the Q2 windfall indefinitely.

Nine quarters of sales · Quarterly sales, $M. These are actual fiscal quarters; fourth quarters are not annual rows.
Q2 FY2024Q2 FY2024: 771.90771.90Q3 FY2024Q3 FY2024: 777.19777.19Q4 FY2024Q4 FY2024: 713.57713.57Q1 FY2025Q1 FY2025: 686.91686.91Q2 FY2025Q2 FY2025: 739.76739.76Q3 FY2025Q3 FY2025: 752.41752.41Q4 FY2025Q4 FY2025: 713.59713.59Q1 FY2026Q1 FY2026: 696.35696.35Q2 FY2026Q2 FY2026: 730.63730.63
Q2 FY2024Q2 FY2024: 771.90771.90Q3 FY2024Q3 FY2024: 777.19777.19Q4 FY2024Q4 FY2024: 713.57713.57Q1 FY2025Q1 FY2025: 686.91686.91Q2 FY2025Q2 FY2025: 739.76739.76Q3 FY2025Q3 FY2025: 752.41752.41Q4 FY2025Q4 FY2025: 713.59713.59Q1 FY2026Q1 FY2026: 696.35696.35Q2 FY2026Q2 FY2026: 730.63730.63
Show the data
MeasureValue
Q2 FY2024771.90
Q3 FY2024777.19
Q4 FY2024713.57
Q1 FY2025686.91
Q2 FY2025739.76
Q3 FY2025752.41
Q4 FY2025713.59
Q1 FY2026696.35
Q2 FY2026730.63
QuarterRevenue $MGross marginEBIT $MOwner NI $MGAAP EPS
Q2 FY2024771.90043.99%28.58913.8240.24
Q3 FY2024777.19442.95%22.81613.0120.24
Q4 FY2024713.57239.60%−25.854−38.168−0.80
Q1 FY2025686.90942.87%−7.907−17.816−0.37
Q2 FY2025739.76243.59%26.14310.5350.21
Q3 FY2025752.41145.14%42.66318.2150.35
Q4 FY2025713.58942.42%−14.220−19.992−0.40
Q1 FY2026696.35045.28%18.8701.1590.02
Q2 FY2026730.63150.01%54.72317.5570.31
Primary 10-Qs and FY2025 release. Gross classification is recast; Q1/Q2 FY2025 use current duty-restated comparisons. Other older earnings remain as then reported; do not sum mixed-basis quarters to claim a restated annual.

There are two different historical comparability changes. Store selling and occupancy costs were moved from cost of sales to operating expenses, lifting the displayed gross margin without changing operating profit. Separately, previously underreported Topo import duties caused restatement of selected prior earnings and balance-sheet rows. Our gross-margin series uses the current expense classification. The current filing supplies corrected Q1 and Q2 FY2025 comparisons, but does not provide a complete revised annual allocation for every older period. We identify that limitation rather than manufacture balancing amounts.

The business

Designer Brands combines a footwear retailer with owned and licensed brands. Retail includes DSW in the United States and Canada, The Shoe Co. and Rubino. Brand Portfolio supplies wholesale customers, direct consumers and DBI’s own stores. The integrated model can improve assortment, distribution and licensing economics, but intercompany sales are not incremental consolidated revenue. The FY2025 annual report combined the former U.S. and Canada retail segments; current comparative segment figures are recast into Retail and Brand Portfolio.

Q2 business, $MCurrentPrior
Retail external revenue671.062686.003
Brand external revenue59.56953.759
Brand intercompany sales26.7119.398
Brand total segment sales86.27973.157
Consolidated external sales730.631739.762
Retail segment profit62.02768.709
Brand segment profit0.979−4.046
Note 11 segment reporting. Do not add gross Brand sales to Retail without eliminating intercompany sales.

Retail external revenue declined 2.2%, with comparable sales down 2.6%. Brand external revenue grew 10.8%; the faster 17.9% segment-sales increase includes intercompany business. The improvement in Brand profit from a loss to a small gain is useful evidence, because segment profit excludes all of the tariff recovery. It is also modest relative to Retail’s $6.682M segment-profit decline. The first half is stronger for Brand Portfolio, with $16.402M profit against a $2.100M prior loss, but the parent still has corporate costs and ownership claims to fund.

Where Retail sales changed · Q2 year-over-year revenue change, $M. Athletic footwear is the largest decline.
Women non-athleticWomen non-athletic: −3.82−3.82Men non-athleticMen non-athletic: −1.86−1.86Kids non-athleticKids non-athletic: −2.00−2.00AthleticAthletic: −12.14−12.14Accessories and otherAccessories and other: 4.884.88
Women non-athleticWomen non-athletic: −3.82−3.82Men non-athleticMen non-athletic: −1.86−1.86Kids non-athleticKids non-athletic: −2.00−2.00AthleticAthletic: −12.14−12.14Accessories and otherAccessories and other: 4.884.88
Show the data
MeasureValue
Women non-athletic−3.82
Men non-athletic−1.86
Kids non-athletic−2.00
Athletic−12.14
Accessories and other4.88

Athletic footwear sales fell $12.144M within Retail while accessories and other increased $4.880M. This mix warns against treating growth in a successful owned athletic brand as proof that the entire athletic retail category is healthy. National brands remain important to traffic and purchasing power. The annual filing says the three largest national-brand suppliers supplied 24% of purchases and Brand Portfolio supplied 10%. A recovery depends on customer relevance and inventory productivity as well as product ownership.

Annual operating contextSource-backed fact
Brand sourcing by units, FY2025China 60%; Cambodia 19%; Vietnam 15%; other 6%
Retail VIP sales share89% in FY2025 versus 86%
WorkforceApproximately 13,000 at January 31, 2026
ABG-Camuto interest40%; licensing and equity income are part of the economics
FY2025 annual report. Customer membership is not a contractual recurring-revenue backlog.

The business has valuable customer access, recognizable brands and a distribution network. It also competes with brands selling directly, large online retailers and specialist footwear chains. Membership sales show repeat engagement, but do not create subscription revenue or protect margins from promotions. The model therefore allows modest sales growth while requiring better cost conversion, rather than attributing software-like durability or recurring margins to a discretionary retailer.

Profit and the refund

The tariff bridge is the central accounting issue. The company recognized $35.536M of tariff-cost recoveries in gross profit. Its adjusted gross-profit reconciliation removes only $15.336M, the amount associated with funding part of the Investor interest payment. The remaining $20.200M is still inside issuer-adjusted gross profit and operating profit. Accordingly, reported gross margin is 50.0%, issuer-adjusted margin is 47.9%, and the margin after removing the full tariff-cost recovery is approximately 45.14%. These are three distinct measures.

Q2 gross-profit bridgeUSD M
Reported gross profit365.355
Issuer adjustment removed−15.336
Issuer adjusted gross profit350.019
Additional retained refund to remove−20.2
Fully ex-recovery gross profit329.819
Fully ex-recovery margin45.14%
Prior restated margin43.59%
Release gross-profit reconciliation; Note 11 full recovery. Full removal is Charged Alpha arithmetic, not an issuer non-GAAP measure.
Three different margins · Percentage points. Underlying gross profitability improves roughly 154 basis points, not the headline 640.
ReportedReported: 50.0150.01Issuer adjustedIssuer adjusted: 47.9147.91Full refund removedFull refund removed: 45.1445.14Prior restatedPrior restated: 43.5943.59
ReportedReported: 50.0150.01Issuer adjustedIssuer adjusted: 47.9147.91Full refund removedFull refund removed: 45.1445.14Prior restatedPrior restated: 43.5943.59
Show the data
MeasureValue
Reported50.01
Issuer adjusted47.91
Full refund removed45.14
Prior restated43.59

Even the fully adjusted comparison is not perfectly “clean” economic profit: it retains the company’s ordinary estimates, compensation, costs and operating equity income. Its purpose is narrow and reproducible: remove the full recorded tariff-cost benefit. The resulting gross-profit improvement is $7.326M, but operating expenses rise $15.950M. Lower impairment expense and other operating lines partly offset that pressure. Q2 operating profit after full recovery removal falls $6.956M from the restated prior quarter. That is a more demanding test than simply observing higher issuer-adjusted earnings.

Reported EBIT to fully ex-refund EBITQ2 $MH1 $M
Reported operating profit54.72373.593
Entire tariff-cost recovery−35.536−35.536
Fully ex-recovery operating profit19.18738.057
Issuer adjusted operating profit39.38758.765
Prior restated reported operating profit26.14318.236
H1 issuer adjustment also adds back $0.508M restructuring. Different measures answer different questions.
EBIT before and after the full recovery · USD millions. Same quarter, different adjustment definitions; the prior comparison is restated.
Q2 reportedQ2 reported: 54.7254.72Q2 issuer adjustedQ2 issuer adjusted: 39.3939.39Q2 full refund removedQ2 full refund removed: 19.1919.19Prior Q2 restatedPrior Q2 restated: 26.1426.14
Q2 reportedQ2 reported: 54.7254.72Q2 issuer adjustedQ2 issuer adjusted: 39.3939.39Q2 full refund removedQ2 full refund removed: 19.1919.19Prior Q2 restatedPrior Q2 restated: 26.1426.14
Show the data
MeasureValue
Q2 reported54.723
Q2 issuer adjusted39.387
Q2 full refund removed19.187
Prior Q2 restated26.143

Before the tariff court ruling, the company sold rights to $18.3M of potential claims for $2.2M cash. During Q2 it received about $36.8M from Customs and remitted $18.3M to the unrelated Investor. The filing treats the remittance as financing: approximately $2.2M principal and $16.1M interest. Selling contingent claims before resolution can transfer legal and timing risk, but the subsequent accounting must reflect the contractual payoff. We do not characterize all $36.8M as freely retained cash, nor subtract the remittance again from the August cash balance.

Issuer Q2 adjusted net-income reconciliationUSD M
Attributable GAAP net income17.557
COGS recovery adjustment−15.336
Related nonoperating interest adjustment−0.761
Investor interest addback16.097
Foreign-exchange adjustment0.006
Redeemable minority income addback2.86
Tax adjustment−1.195
Issuer adjusted net income19.228
Exact non-GAAP table. The three tariff financing adjustments net to zero before tax; this is not a full removal of the net windfall.

Earnings quality

The EPS denominator and ownership scope matter as much as the numerator. Quarterly diluted weighted shares rose to 55.974M from 49.734M. GAAP income attributed to DBI is after the $2.860M Topo minority attribution; company adjusted net income adds that minority line back. An investor should not value the adjusted EPS as if it automatically represented earnings owned entirely by the public common shares. Our enterprise approaches include the consolidated operating business, then explicitly deduct a modeled minority claim.

Topo’s historical duty error is separate from the IEEPA refund transaction. The company found incorrect import-duty rates affecting pre- and post-acquisition periods, with an estimated five-year obligation of about $8.4M including interest. It considered the prior-period errors individually immaterial but their aggregate correction material to the current first quarter, so it revised comparative statements. That is a control and diligence question, not a reason to label every restated dollar a current cash expense or to erase the duty liability from the capital analysis.

Restatement illustration, $MPreviously reportedCurrent comparative
Q2 FY2025 attributable net income10.82710.535
H1 FY2025 attributable net loss−6.597−7.281
Jan31 accrued expenses170.014178.43
Jan31 redeemable NCI5.2741.616
Jan31 equity282.486280.0
Prior H1 CFO1.0771.077
Note 12. Cash-flow restatement reallocates reconciling lines without changing total prior H1 CFO.

Current receivables include $25.3M of insured legal settlement obligations paired with related accrued liabilities. That pairing explains part of the rising balance and prevents treating every receivable dollar as a customer-demand signal. It also does not make collection and settlement timing disappear. The allowance for credit losses is only $0.431M against gross receivables of $80.828M, while $26.818M of customer receivables carry third-party payment guarantees. The mix needs to be read before interpreting a simple receivables-to-sales ratio.

The annual auditor is Deloitte & Touche, with an audit report dated March 30, 2026. That report applies to the annual statements as issued; it is not a separate audit opinion on the September release or a guarantee against later corrections. Inventory valuation remains judgment-sensitive: the annual report estimates a 10% increase in markdown, shrink and aging reductions would raise cost of sales by roughly $4M. We retain inventory risk, stock compensation and ordinary restructuring pressure in the economic assessment. The question is whether improved margins survive those costs, not whether every noncash line can be added away.

Provider and primary-source policyTreatment
Earnings consensusSaved provider update is after the release; clean preprint EPS basis and share adjustment not established
Adjusted EPS beat/missNo fabricated comparable-consensus beat claimed
Historical fundamentalsActual SEC rows govern; provider originals retained
Old gross-margin seriesRecast to current cost presentation using primary comparative rows
Equity investment incomeRetained in EBIT; no separate investment-book-value addition
Raw URLs, hashes and row headers are retained with the source audit.

Cash and capital claims

H1 operating cash flow was $48.236M and cash capital expenditure was $22.251M, producing $25.985M ordinary free cash flow. Management identifies a rounded $20.7M favorable operating-cash contribution from the refund net of the Investor interest remittance. Subtracting that rounded figure leaves roughly $5.3M FCF, but this is an illustration, not certified normalized cash: related tax payments, claim timing and working-capital movements are not isolated to a precise tax-adjusted basis. The $2.2M Investor principal is a financing flow, distinct from the operating-interest payment.

H1 CFO bridgeUSD M
Consolidated net income23.871
Depreciation and amortization28.267
Stock compensation14.52
Deferred taxes5.864
Equity income reversal−4.926
Equity distributions received5.965
Other noncash0.528
Receivables cash use−18.714
Inventory cash use−32.872
Prepaids cash source1.598
Payables cash source21.519
Accrual cash source7.133
Operating lease net cash use−4.517
Operating cash flow48.236
Cash capital expenditure−22.251
CFO less cash capex25.985
Cash-flow statement. SBC is a cash reconciliation addback here, but remains an economic compensation cost in valuation.
Nine quarterly cash outcomes · CFO less cash capex, $M; YTD cash statements differenced into quarters. Refund included in current Q2.
Q2 FY2024Q2 FY2024: 27.9927.99Q3 FY2024Q3 FY2024: −19.19−19.19Q4 FY2024Q4 FY2024: 58.1258.12Q1 FY2025Q1 FY2025: −27.59−27.59Q2 FY2025Q2 FY2025: 11.9211.92Q3 FY2025Q3 FY2025: 57.5057.50Q4 FY2025Q4 FY2025: 36.4336.43Q1 FY2026Q1 FY2026: −31.90−31.90Q2 FY2026Q2 FY2026: 57.8957.89
Q2 FY2024Q2 FY2024: 27.9927.99Q3 FY2024Q3 FY2024: −19.19−19.19Q4 FY2024Q4 FY2024: 58.1258.12Q1 FY2025Q1 FY2025: −27.59−27.59Q2 FY2025Q2 FY2025: 11.9211.92Q3 FY2025Q3 FY2025: 57.5057.50Q4 FY2025Q4 FY2025: 36.4336.43Q1 FY2026Q1 FY2026: −31.90−31.90Q2 FY2026Q2 FY2026: 57.8957.89
Show the data
MeasureValue
Q2 FY202427.99
Q3 FY2024−19.19
Q4 FY202458.12
Q1 FY2025−27.59
Q2 FY202511.92
Q3 FY202557.50
Q4 FY202536.43
Q1 FY2026−31.90
Q2 FY202657.89
QuarterCFO $MCapex $MFCF $MD&A $MSBC $M
Q2 FY202441.57813.59027.98816.4485.865
Q3 FY2024−9.7619.429−19.19015.7483.571
Q4 FY202470.09911.98158.11815.2463.668
Q1 FY2025−20.3667.229−27.59514.7966.103
Q2 FY202521.4439.52411.91914.8685.960
Q3 FY202566.5309.03157.49914.7153.383
Q4 FY202542.2535.82136.43214.7003.544
Q1 FY2026−22.0339.869−31.90214.3806.468
Q2 FY202670.26912.38257.88713.8878.052
Quarter derivations and original YTD headers retained in historical_financials.json.

Inventory consumed $32.872M of H1 cash while receivables consumed $18.714M; payables and accruals supplied cash. Ending inventory of $594.688M is lower than the prior-year $610.876M but higher than the January seasonal low. Those comparisons answer different questions. Cash increased only $0.720M to $51.591M after investing, financing and currency movements. The cash balance already reflects the completed refund and Investor remittance. Future working-capital releases are not an automatic source of value in our forecast.

Enterprise-to-common bridgeUSD M
ABL including FILO309.723
Term loan face principal116.25
Total face funded debt425.973
Inferred current finance leases29.462
Analyst Topo minority allowance15.0
Analyst operating cash reserve20.0
Recorded cash credit−51.591
Net enterprise claims deducted438.844
Debt face exceeds carrying debt by $2.914M deferred fees. Finance lease estimate = January $30.791M less $1.329M H1 principal; no new additions disclosed. FX/modification uncertainty remains.
The funded obligations ahead of common · USD millions. FILO already sits inside ABL; finance leases estimated from annual principal less H1 payments.
ABL including FILOABL including FILO: 309.72309.72Term loan faceTerm loan face: 116.25116.25Inferred finance leasesInferred finance leases: 29.4629.46
ABL including FILOABL including FILO: 309.72309.72Term loan faceTerm loan face: 116.25116.25Inferred finance leasesInferred finance leases: 29.4629.46
Show the data
MeasureValue
ABL including FILO309.723
Term loan face116.250
Inferred finance leases29.462

The ordinary revolver rate was 6.0%; the term loan carried 10.8% cash interest and a higher effective rate including fees. The term loan matures in June 2028, and the revolving facility has an earlier-maturity provision linked to it despite a later outside date. The $29.5M FILO sits inside total ABL debt and must not be added twice. Availability of roughly $146.2M under the borrowing base is a contingent funding resource, not cash or an asset to add to fair value. Both facilities are secured and subject to liquidity-linked covenants.

Finance lease obligations belong with debt-like claims because finance lease amortization remains in operating profit while its interest is below EBIT. Operating leases of $785.957M are treated differently: rent remains in forecast operating costs, so adding that liability to the same valuation would mix lease conventions. This does not mean stores are free or leases harmless. H1 operating-lease cash payments were $106.670M; finance leases used another $1.363M operating interest and $1.329M financing principal. A $20M cash reserve is our seasonal funding assumption, with zero and $40M sensitivities; it is not a company-designated restriction.

Recorded shares and modeling allowances · Millions of shares. Gross units, possible overlap and uncertain vesting mean these are not equivalent GAAP share measures.
Reported A+BReported A+B: 51.0451.04A+B plus current RSUsA+B plus current RSUs: 64.4564.45Gross modelGross model: 66.0066.00Stress share caseStress share case: 69.0069.00
Reported A+BReported A+B: 51.0451.04A+B plus current RSUsA+B plus current RSUs: 64.4564.45Gross modelGross model: 66.0066.00Stress share caseStress share case: 69.0069.00
Show the data
MeasureValue
Reported A+B51.038
A+B plus current RSUs64.447
Gross model66.000
Stress share case69.000
Common ownership and possible awardsMillions
Reported outstanding A + B51.038
Quarter weighted basic / diluted50.894 / 55.974
Current time-based / performance RSUs9.760 / 3.649
Outstanding plus all current RSUs64.447
January director units1.1; already in basic EPS; overlap unresolved
Gross modeling denominator66.0
Notes 4–6 and annual compensation note. 66M is an overlap-possible allowance, not exact new issuance or GAAP diluted shares; no exercise proceeds credited.

Class A and B have the same economic rights and B can convert one-for-one, but B carries eight votes per share against one for A. Schottenstein affiliates control roughly 64% of votes with about 27% economic ownership. Treasury shares are excluded from outstanding common. The 66M model deliberately allows for substantial awards without claiming every performance unit vests or adding January director units twice to an EPS-derived denominator. Compensation stays in economic margins as an ongoing labor cost. Topo’s remaining 20.6% has a performance-linked put/call; the $6.232M book amount is remeasured and is not a guaranteed eventual settlement. Our $15M allowance, about 2.4 times book, is a stress assumption with a broad sensitivity, not contractual precision.

Valuation

All three routes use the August 1 financial anchor. The DCF models only the remaining half of FY2026 and then FY2027–FY2030, with cash at 0.5, 1.5, 2.5, 3.5 and 4.5 years. We compare that value with the later September 10 market quote without inventing an interim cash bridge. Already realized H1 cash is in the balance sheet and is not forecast again. Taxes, reinvestment and working capital are explicit, and stock compensation and operating rent remain in profit. The annual guide is a reasonableness check; our normalized operating forecasts are not company guidance.

DCF period$M revenueEBIT marginEBITD&AReinvestNWC useFCFFYears
H2 FY20261480.1531.49%22.00028.00025.0000.00018.4000.5
FY20272965.2772.80%83.02856.00052.0002.00060.1191.5
FY20283024.5833.20%96.78757.00054.0002.00068.7512.5
FY20293085.0743.50%107.97858.00056.0002.00075.5843.5
FY20303146.7763.80%119.57759.00058.0002.00082.7044.5
FCFF = EBIT × 70% + D&A − reinvestment − NWC cash use. Analyst assumptions; no automatic seasonal release.

FY2026 sales start at the midpoint of the issuer’s flat-to-1% growth range, or $2,907.134M, leaving $1,480.153M in H2 after actual H1. We assume $22M H2 operating profit excluding refunds, producing $60.057M for the full year. Prior H2 reported EBIT was $28.443M on its then-reported basis, so this assumption does not require an immediate record finish. H2 D&A of $28M, reinvestment of $25M and no working-capital release yield $18.4M unlevered cash. Tax at 30% is a normalized assumption below the current 37.7% H1 effective rate, making sustained nondeductible costs an adverse sensitivity.

The more demanding step is FY2027: sales grow 2%, but EBIT rises to $83.028M and margin reaches 2.8%. That requires about $22.97M more profit than our FY2026 core model. If the roughly $58M incremental revenue contributes 45% gross profit, it supplies about $26M before incremental operating costs; thus the forecast permits only a modest cost increase and requires strong cost control. This is a recovery assumption, not simple top-line extrapolation. By FY2030, margin reaches 3.8%, still below a retail business with exceptional economics but materially above recent DBI annual outcomes.

Remaining and forward unlevered cash · Analyst FCFF, $M. H2 FY2026 is a half-year stub; all later periods are full years.
H2 FY2026H2 FY2026: 18.4018.40FY2027FY2027: 60.1260.12FY2028FY2028: 68.7568.75FY2029FY2029: 75.5875.58FY2030FY2030: 82.7082.70
H2 FY2026H2 FY2026: 18.4018.40FY2027FY2027: 60.1260.12FY2028FY2028: 68.7568.75FY2029FY2029: 75.5875.58FY2030FY2030: 82.7082.70
Show the data
MeasureValue
H2 FY202618.40
FY202760.12
FY202868.75
FY202975.58
FY203082.70
Valuation routeEnterprise $MCommon / shareWeight
DCF726.974$4.36650%
Economic NOPAT663.455$3.40330%
Revenue EV569.587$1.98120%
Each deducts the same $438.844M current claim bridge and divides by 66M shares. Blend $3.59996; base rounds to $3.50 at $0.25 increments.
Three common-share values · USD per modeled share; same $438.844M claim deduction and 66M denominator.
DCFDCF: $4.37$4.37Economic NOPATEconomic NOPAT: $3.40$3.40Revenue EVRevenue EV: $1.98$1.98Weighted route blendWeighted route blend: $3.60$3.60
DCFDCF: $4.37$4.37Economic NOPATEconomic NOPAT: $3.40$3.40Revenue EVRevenue EV: $1.98$1.98Weighted route blendWeighted route blend: $3.60$3.60
Show the data
MeasureValue
DCF4.366
Economic NOPAT3.403
Revenue EV1.981
Weighted route blend3.600

The DCF uses a 12% discount rate and 2% perpetual growth. Terminal value contributes most of enterprise value, so the terminal cash margin deserves more scrutiny than a neat near-term spreadsheet. The economic-profit route capitalizes FY2028 after-tax operating profit at 13 times and discounts it 2.5 years. That is an enterprise NOPAT multiple, not a common-equity P/E; it therefore still requires the funded-claim deduction. The revenue route uses 0.25 times FY2028 sales, equivalent to 7.81 times the modeled EBIT before discount. These two terminal cross-checks intentionally give no separate credit for interim cash generation. They are corroborating lenses, not statistically independent forecasts.

Capital sensitivityRoute-weighted $/share
Shares 51.038M4.655
Shares 64.447M3.687
Shares 66.000M3.600
Shares 69.000M3.443
Cash reserve $0M3.903
Cash reserve $20M3.600
Cash reserve $40M3.297
Topo claim $6.232M3.733
Topo claim $15.000M3.600
Topo claim $30.000M3.373
Topo claim $50.000M3.070
One assumption changes at a time. Reported outstanding shares are a sensitivity, not a replacement for award analysis.
DCF discount rateTerminal growthDCF $/share
10%0%5.024
10%2%7.268
10%3%8.871
12%0%2.961
12%2%4.366
12%3%5.302
14%0%1.493
14%2%2.436
14%3%3.037
The DCF-only range is wider than the blended base. Low discount rates are not guaranteed by current financing access.

The reference price requires $834.184M enterprise value under the model’s capital assumptions. In the economic-NOPAT route, that implies roughly 4.02% FY2028 EBIT margin rather than our 3.2%, at the same revenue, tax, multiple and discount rate. Alternatively it requires a larger multiple, less dilution, lower claims or a combination. This is the constructive bull case: a stronger brand mix and healthier retail demand can create operating leverage. The bear case is that customer softness and refinancing costs absorb the recovery while the common claim remains a thin residual.

Our bear/base/bull equity values are $1/$3.50/$8 with subjective 30%/50%/20% weights, giving $3.65 weighted value. Their enterprise values are $504.844M/$669.844M/$966.844M under the same claim bridge. Holding claims constant isolates operating outcomes; an actual strong Topo outcome could also enlarge the minority settlement, while a weak case could worsen financing. The conditional $2.45 entry is exactly 30% below base. It is an analytical review threshold, not an automatic order: cash availability, duty resolution and recurring profit must remain consistent with the thesis.

Guidance and the Street

Management raised FY2026 sales guidance from minus 1% to plus 1% growth to flat through plus 1%, and lifted adjusted EPS from $0.28–$0.38 to $0.47–$0.52. The sales midpoint increases only half a percentage point; the EPS midpoint rises 50% from $0.33 to $0.495. The improvement is substantial on the issuer’s definition, but the footnote excludes selected tariff-financing items rather than the entire refund benefit. The guidance also excludes specified minority, foreign-exchange, restructuring, duty-interest and tax items. Calling it a pure recurring-EPS upgrade would overstate what the source establishes.

FY2026 guidePrior June releaseCurrent September release
Sales growth−1% to +1%0% to +1%
Adjusted diluted EPS$0.28–$0.38$0.47–$0.52
Revenue midpoint algebra$2,892.671M$2,907.134M
EPS midpoint$0.33$0.495
Prior guide; current guide and exclusions. Revenue algebra applies growth to FY2025 actual sales.

H1 issuer-adjusted EPS is $0.41, but subtracting it from the annual EPS range does not produce exact standalone H2 EPS because weighted share counts and exclusions can change. As a rough hurdle only, the annual midpoint leaves $0.085 beyond H1 on the issuer’s EPS basis. We do not translate that into a certified H2 profit forecast. The stronger analytic check is the full source-backed revenue and operating-profit bridge, including the fact that the last two fourth quarters had operating losses even when the broader fall season supported cash generation.

ComparisonWall StreetCharged Alpha
RatingCurrent comparable consensus unverifiableSELL; 3/5 conviction
Target / fair valueUBS $6 dated Sep1 provider record; preprintBase $3.50; Aug1 financial anchor
AlignmentDated target above our valueMore cautious on common residual value
FMP saved target-news data; complete broker model and current rating not obtained. No invented consensus rating.

The latest saved target record is a September 1 UBS reduction to $6 from $7.50. Older observations refer to different information sets. The provider also returns a “Hold” aggregate without a sufficiently clear date or active coverage universe, and annual estimates often show one analyst. We retain those raw records but do not pass them off as a verified current multi-analyst consensus. The saved earnings record lists adjusted EPS and revenue estimates updated after the release; that timing and the uncertain adjustment basis prevent a clean preprint beat/miss claim.

Management and allocation

Douglas Howe is chief executive and Sheamus Toal is chief financial officer in the current filings. The investment case depends on management’s ability to convert assortment and sourcing changes into recurring cash while honoring secured lenders and minority holders. We give credit for lower funded debt and a better first half, while recognizing that a portion of cash improvement came from a legal recovery and that the gross-margin presentation changes can obscure the underlying comparison. Corporate costs, award growth and acquisition accounting remain relevant tests of execution.

Three annual periodsRevenue $MGross marginEBIT $MOwner NI $MCFO $MCapex $MFCF $M
FY20233074.97643.06%72.40129.062162.39954.997107.402
FY20243009.26242.73%34.933−10.54982.23650.89131.345
FY20252892.67143.57%47.764−8.374109.86031.60578.255
FY2025 annual comparative statements. FY2023 has 53 weeks versus 52 in FY2024 and FY2025. Annual earnings are as then reported; later duty revisions not completely allocated.

Revenue has declined across these three annual periods, while cash flow varies with inventory, receivables and tax timing. The FY2024 cash-flow statement included a $44.476M income-tax-receivable release, illustrating why cash conversion should be assessed across years. Acquisitions used $127.496M in FY2023 and $16.144M in FY2024. They are separate from ordinary capex and therefore not inside the simple FCF chart, but they were real uses of capital. A brand strategy should earn back its purchase price and minority obligations, not merely expand segment revenue.

Repurchases used $102.188M in FY2023 and $68.553M in FY2024, with no cash repurchases in FY2025 and treasury shares unchanged through the current half. H1 dividends cost $4.961M and share-award tax withholding used $4.298M. The board declared another $0.05 dividend per share, payable October 7 to September 24 holders. Those commitments may be modest individually, but they compete with seasonal inventory, debt service and reinvestment. With dual-class voting control, public investors have limited influence over that allocation.

Annual ordinary free cash flow · CFO less cash capex, $M. Excludes acquisition cash and buybacks; working-capital and tax timing remain inside CFO.
FY2023FY2023: 107.40107.40FY2024FY2024: 31.3431.34FY2025FY2025: 78.2578.25
FY2023FY2023: 107.40107.40FY2024FY2024: 31.3431.34FY2025FY2025: 78.2578.25
Show the data
MeasureValue
FY2023107.40
FY202431.34
FY202578.25

The annual report’s Topo measurement policy adjusts the redeemable interest for attributable earnings and, when applicable, changes needed to reach the higher of redemption value or carrying value. That means H1 minority attribution cannot safely be annualized as ordinary recurring earnings. The source does not give us a complete contractual future payout formula. Our explicit claim allowance and sensitivity reflect that uncertainty. We would prefer a transparent settlement timetable and reconciliation over a valuation that silently assumes all consolidated brand profits belong to common shareholders.

Risks and counterarguments

The strongest counterargument to our Sell is that the recovery is already visible beneath the windfall. Fully ex-refund gross margin improves, Brand Portfolio’s first-half profit turns positive, and face funded debt falls sharply year over year. If retail traffic stabilizes and fixed costs grow slowly, a small margin increase on nearly $3B of sales can add tens of millions to operating profit. Our bull case recognizes that leverage. A bearish view that ignores the real first-half improvement would be incomplete.

The main downside risk is a mismatch between cash needs and reported profit. Inventory must be purchased before it sells, secured borrowing availability can change with collateral, and June 2028 refinancing approaches before a distant terminal value is earned. Tariff policy and remaining import-duty corrections can alter sourcing costs or cash timing. The company has not isolated every tax consequence of the refund financing for a precise normalized cash measure. An attractive quarterly EPS figure therefore cannot replace a liquidity bridge.

RiskEconomic consequenceEvidence to watch
Retail demand and markdownsGross-profit gains lost to clearance or traffic declinesComps, inventory aging, full ex-refund margin
Funding and finance leasesCommon residual squeezed by debt-like obligationsBorrowing base, rates, covenant headroom, lease principal
Topo minority settlementConsolidated brand success may enlarge another holder’s claimPut/call disclosures and remeasurement
Award issuanceMore claims on the same business valueCurrent units, settlements, basic/diluted share bridge
Duty and settlement accountingAccrual/receivable timing can obscure cashRestatement roll-forward and actual payments
Forward tests are analytical judgments, not statements that a breach has occurred.

Valuation risk also runs in both directions. The $20M cash reserve may be too large if cash proves genuinely surplus, or too small in a difficult seasonal cycle. The 66M denominator is deliberately gross and may exceed eventual issued shares if awards lapse; it may be insufficient if new grants or capital raising continue. The Topo allowance is not a certified contract value. Sensitivities show how these choices affect the common residual. High uncertainty is a statement about the width of plausible outcomes, not permission to hide the assumptions.

What changes the call

Our next review deadline is December 15, 2026, intended to capture the next quarterly filing; this is not a company-confirmed release date. A constructive result would combine nonnegative Retail comparable sales, gross margin of at least 45.5% after removing all new tariff recoveries, and underlying operating profit of at least $35M. Any new windfall must be bridged separately before applying those tests. We would also want funded debt and finance lease claims to fall through cash generation rather than a temporary working-capital squeeze.

Adverse evidence includes Retail comps below minus 4%, fully ex-recovery gross margin below 44%, or underlying quarterly EBIT below $20M. Cash below $35M without a clear seasonal funding explanation, total face debt plus estimated finance leases above $475M, or new potential share claims taking the gross allowance above 69M would require another valuation pass. These are monitoring thresholds, not loan covenants. A better price alone cannot fix a deteriorating business, while better durable margins could lift value before the stock reaches our conditional entry.

Review testCurrent baselinePositiveAdverse
Retail comps−2.6%At least 0%Below −4%
Full ex-refund gross margin45.14%At least 45.5%Below 44%
Full ex-refund EBIT$19.187M Q2At least $35M next Q3Below $20M
Cash$51.591MStable with explained seasonal fundingBelow $35M unexplained
Face debt + finance leases$455.435M estimatedDeclining with cash generationAbove $475M
Gross potential-share model66M assumptionNo unexplained growthAbove 69M
Review by December 15, 2026. Company reporting date not verified; thresholds are Charged Alpha tests.

This packet does not claim a verified track record against an earlier DBI research packet. Prior-period media identity was reconciled for admission, but a prior frozen signpost scorecard was not available to this research pass. We start with a transparent current baseline. The call is falsifiable: improving customer demand and economic margins, controlled dilution and a clearer financing path can overturn it. A repeat of adjusted EPS growth fueled by recoveries or minority addbacks would not, by itself, do so.

Sources and methods

Primary evidence governs the analysis: the September 10 earnings release and current 10-Q, the June quarter, the FY2025 annual report, and quarterly and annual releases covering nine quarters and three complete fiscal years. Original downloaded HTML and submission documents are retained with source URLs, fetch times and SHA-256 hashes. Parsed tables preserve their actual row headers and dates. Current filing comparisons override older provider rows when restatements or cost classifications differ.

Primary sourcePeriod / role
September 10 releaseQ2 FY2026 print, guidance and exact adjustments
Current Form 10-QAugust 1 balance sheet, cash flow, Investor, duties, shares and segments
June releasePrior FY2026 guidance
FY2025 Form 10-KThree annual statements, finance leases, Topo rights, awards and control
FY2025 full-year releaseQ4 actual EPS and consistent quarterly comparatives
All underlying historical filing URLs and hashes are retained in the source manifest.

Amounts in the working financial history are thousands of U.S. dollars unless labeled otherwise; display tables generally convert to millions. Quarterly cash figures are derived from cumulative cash-flow statements by subtraction. Fourth-quarter earnings use full-year less nine-month figures on a consistent reporting basis, while fourth-quarter EPS comes from the actual release because EPS cannot generally be subtracted across weighted share counts. We do not arbitrarily scale provider fundamentals, treat an annual row as a quarter, or fill unavailable corrected history with estimates.

The three valuation routes are independent arithmetic checks on the same operating judgment, so their weights are editorial choices rather than statistical probabilities. Scenario weights are also subjective. The enterprise bridge uses debt face value, an inferred finance-lease roll-forward, a minority allowance and a seasonal cash reserve, with common shares modeled gross. Capitalized operating equity income is not supplemented by investment book value. Operating rent remains in EBIT; finance lease debt is included. These conventions make the residual claim understandable even where the filing leaves a future settlement amount uncertain.

No original broker research model, verified current consensus-rating population or authoritative transcript of the current call was obtained. Management commentary here comes from actual releases and filings. The current quote and target-news records are saved provider data, with their dates and limitations. Visuals use the channel’s established studio assets and self-authored financial tables; no unverified third-party photograph, logo license or media credit is asserted. Raw source retention allows a reviewer to reproduce the numbers without relying on the prose.